Your brand is a cornerstone of your prosperity—but a brand is only as strong as the team protecting it. You’ve built your brand, marks and reputation into fundamental assets. Count on the global intellectual property lawyers at Dentons to defend them.

Enact a comprehensive trademark acquisition, protection and policing strategy, supported by partners with extensive experience in the dense world of intellectual property law. Monitor these key assets vigilantly and react quickly to potential discrepancies or threats. Deploy the appropriate legal remedies when challenges arise. Maximize brand value through contractual and licensing arrangements. Maintain that value through rigorous enforcement.

As the expansion of digital markets magnifies the risks to intellectual property, Dentons works continuously to preserve your vital brand elements. Our expertise addresses every aspect of trademark strategy, including:

• Infringement, unfair competition and passing off
• Brand clearance advice
• Licensing and exploitation
• Strategic IP structuring
• Portfolio evaluation, prosecution (direct and through trusted relationships) and management
• Trade dress and brand due diligence
• Dilution
• Domain name registration and management, including combating cybersquatting
• Comparative advertising and legitimate fair use of third-party trademarks
• Investigation, computer forensics and e-Discovery lab
• Media and entertainment industry issues
• Customs seizures
• Anti-counterfeiting

Recognition

Dentons lawyers shine in The Legal 500 Hall of Fame

March 1, 2018

Dentons is proud to announce that 17 of our lawyers from Africa, Europe, Middle East and the United States have made it into The Legal 500 Hall of Fame, as lawyers at the pinnacle of the profession.

Dentons recognized by Best Lawyers in America in 200 categories

August 15, 2017

Dentons, the world's largest law firm, has been recognized by The Best Lawyers in America in 200 categories in the 2018 edition of the highly regarded publication. The ranking highlights 138 individual lawyers from Dentons, including nine who have been recognized for more than 25 years, 51 who have been listed for 10 years and 12 who were included for the first time.

Dentons secures 141 individual and 42 practice rankings in Legal 500 US 2017

June 6, 2017

Dentons earned 141 individual and 42 practice rankings in the most recent edition of Legal 500 US 2017, an annual legal directory, which catalogues the nation's best lawyers and law firms based on in-depth research and interviews.

View all recognition for Trademarks

Insights

First competition fine imposed for ban on online search advertising

December 20, 2018

The European Commission (EC) has fined fashion company Guess almost €40m for restricting its authorised retailers from advertising the brand online and making cross-border sales.

New Year, new trade mark laws in Australia to take stock of in 2019

December 13, 2018

The beginning of the new year is an opportune time for trade mark owners to audit their Australian IP portfolio and licensing arrangements. In light of recent amendments to the Trade Marks Act, we recommend that trade mark owners commit to a couple of New Year’s resolutions.

Key changes to Canada’s trademark law

December 6, 2018

Nearly five years after the Government of Canada tabled a number of intellectual property law treaties to harmonize Canada’s patent, trademark and industrial design laws with international laws, the long-awaited coming into force date has finally been announced for the Trade-marks Act (Act)– June 17, 2019 (CIF Date).

View all insights for Trademarks

News and Events

Recent Press Releases

Dentons advises Bayer in the largest action against drug counterfeiters to date

May 19, 2015

Global law firm Dentons represented Bayer Healthcare under civil and criminal law in connection with the complex “Pillendienst” case. The defendants in this procedure, among them Matthias M., considered to be one of the founders of the “Pillendienst”, were accused of criminal trademark infringement, criminal offences under the Medicinal Products Act and conspiracy to defraud.